Beren H. Tomooka

1.9k total citations
17 papers, 1.4k citations indexed

About

Beren H. Tomooka is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Beren H. Tomooka has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 11 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Beren H. Tomooka's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Systemic Lupus Erythematosus Research (10 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Beren H. Tomooka is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Systemic Lupus Erythematosus Research (10 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Beren H. Tomooka collaborates with scholars based in United States, Netherlands and France. Beren H. Tomooka's co-authors include William H. Robinson, Lawrence Steinman, Raymond A. Sobel, David A. Hafler, Shalina S. Ousman, Eric F. Wawrousek, Johannes M. van Noort, Brian Kidd, Wolfgang Hueber and Peggy P. Ho and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Beren H. Tomooka

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beren H. Tomooka United States 15 573 556 454 410 141 17 1.4k
Harald Illges Germany 21 228 0.4× 479 0.9× 224 0.5× 772 1.9× 59 0.4× 57 1.4k
Kunihiko Yamaki Japan 24 361 0.6× 541 1.0× 153 0.3× 313 0.8× 72 0.5× 57 1.6k
Ching Chen United States 20 213 0.4× 619 1.1× 420 0.9× 1.0k 2.4× 177 1.3× 31 1.9k
Kathy Strauch United States 9 188 0.3× 336 0.6× 227 0.5× 919 2.2× 58 0.4× 10 1.3k
Jodi L. Karnell United States 17 315 0.5× 279 0.5× 133 0.3× 789 1.9× 158 1.1× 22 1.4k
Remedios Nazareno United States 13 294 0.5× 428 0.8× 113 0.2× 492 1.2× 87 0.6× 14 1.3k
Arthur H. Tatum United States 24 115 0.2× 433 0.8× 247 0.5× 298 0.7× 190 1.3× 50 1.7k
Mais Hashem Saudi Arabia 23 166 0.3× 1.1k 1.9× 156 0.3× 336 0.8× 65 0.5× 51 1.8k
Iris Ferber United States 8 159 0.3× 463 0.8× 109 0.2× 1.2k 3.0× 258 1.8× 8 1.9k
Seng Song Canada 19 94 0.2× 258 0.5× 333 0.7× 496 1.2× 165 1.2× 24 1.3k

Countries citing papers authored by Beren H. Tomooka

Since Specialization
Citations

This map shows the geographic impact of Beren H. Tomooka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beren H. Tomooka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beren H. Tomooka more than expected).

Fields of papers citing papers by Beren H. Tomooka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beren H. Tomooka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beren H. Tomooka. The network helps show where Beren H. Tomooka may publish in the future.

Co-authorship network of co-authors of Beren H. Tomooka

This figure shows the co-authorship network connecting the top 25 collaborators of Beren H. Tomooka. A scholar is included among the top collaborators of Beren H. Tomooka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beren H. Tomooka. Beren H. Tomooka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Haren, Keith Van, Beren H. Tomooka, Brian Kidd, et al.. (2013). Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing– remitting multiple sclerosis. Multiple Sclerosis Journal. 19(13). 1726–1733. 35 indexed citations
2.
Ho, Peggy P., Lowen Y. Lee, Xiaoyan Zhao, et al.. (2009). Autoimmunity against Fibrinogen Mediates Inflammatory Arthritis in Mice. The Journal of Immunology. 184(1). 379–390. 51 indexed citations
3.
Hueber, Wolfgang, Beren H. Tomooka, Franak Batliwalla, et al.. (2009). Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Research & Therapy. 11(3). R76–R76. 86 indexed citations
4.
Monach, Paul A., Wolfgang Hueber, Benedikt M. Kessler, et al.. (2009). A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis. Proceedings of the National Academy of Sciences. 106(37). 15867–15872. 82 indexed citations
5.
Robinson, William H., Beren H. Tomooka, Rafael Valle‐Oñate, et al.. (2008). Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. 25 indexed citations
6.
Romero‐Sánchez, Consuelo, William H. Robinson, Beren H. Tomooka, et al.. (2008). Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clinical Rheumatology. 27(11). 1429–1435. 28 indexed citations
7.
Zhao, Xiaoyan, Nwora Lance Okeke, Orr Sharpe, et al.. (2008). Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Research & Therapy. 10(4). R94–R94. 142 indexed citations
8.
Kidd, Brian, Peggy P. Ho, Orr Sharpe, et al.. (2008). Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Research & Therapy. 10(5). R119–R119. 95 indexed citations
10.
Britschgi, Markus, Yoshiko Takeda‐Uchimura, Kaspar Rufibach, et al.. (2008). P2‐294: Microarray profiling reveals autoantibody reactivities against abnormal amyloid peptide conformations decline with age and in Alzheimer's disease. Alzheimer s & Dementia. 4(4S_Part_14).
11.
Ousman, Shalina S., Beren H. Tomooka, Johannes M. van Noort, et al.. (2007). Protective and therapeutic role for αB-crystallin in autoimmune demyelination. Nature. 448(7152). 474–479. 420 indexed citations
12.
Ousman, Shalina S., Beren H. Tomooka, Eric F. Wawrousek, et al.. (2007). Protective and Therapeutic Role for α B-Crystallin in Autoimmune Demyelination. Clinical Immunology. 123. S139–S139. 19 indexed citations
13.
Hueber, Wolfgang, Beren H. Tomooka, Franak Batliwalla, et al.. (2007). Proteomic Signatures of Secreted Proteins for the Prediction of Treatment Response to TNF Blockers in RA. Clinical Immunology. 123. S94–S94. 1 indexed citations
14.
Hueber, Wolfgang, Beren H. Tomooka, Xueming Zhao, et al.. (2006). Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Annals of the Rheumatic Diseases. 66(6). 712–719. 109 indexed citations
15.
Ho, Peggy P., Julian P. T. Higgins, Brian Kidd, et al.. (2006). Tolerizing DNA vaccines for autoimmune arthritis. Autoimmunity. 39(8). 675–682. 18 indexed citations
16.
Ho, Peggy P., Paulo Fontoura, Michael Platten, et al.. (2005). A Suppressive Oligodeoxynucleotide Enhances the Efficacy of Myelin Cocktail/IL-4-Tolerizing DNA Vaccination and Treats Autoimmune Disease. The Journal of Immunology. 175(9). 6226–6234. 47 indexed citations
17.
Hueber, Wolfgang, Brian Kidd, Beren H. Tomooka, et al.. (2005). Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis & Rheumatism. 52(9). 2645–2655. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026